Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT06896890 · RECRUITING

Trial details

NCT number: NCT06896890
Sponsor: Inhatarget Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NSCLC (advanced Non-small Cell Lung Cancer)Stage IV Lung Cancer

Start date: 2023-06-23
Primary completion: 2026-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.